Alembic Pharmaceuticals has received a tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Bimatoprost Ophthalmic Solution, 0.03 per cent.

The orders comprise of providing necessary infrastructure facilities like furniture, additional class rooms including library rooms and electrical facilities in all the government schools in five districts.

Following stocks are close to their 52-week low as at 12.40 p.m. on August 6, 2018.

Mercator Limited has bagged Maintenance Dredging Contract of Rs. 26.39 crore from Goa Naval. The contract is for block year 2018-20, 50 per cent of the project is to be completed in FY 2019 and the remaining in the FY 2020.

The jump in volume was primarily due to the investment in brands and widening the distribution network through focus on direct reach, rural market and weak states.

The markets on August 6, 2018 opened gap up. BSE Sensex is trading at 37,736.54, up by 180.38 points and the Nifty is trading at 11,398.70, up by 37.90 points. 

Overall volumes in futures & options currently stand at 50.56 lakh contracts with a turnover of Rs. 4,72,158.52 crore.

Overall volumes in futures & options currently stand at 50.56 lakh contracts with a turnover of Rs. 4,72,158.52 crore.

The stock of generic drug manufacturer Glenmark Pharma halts after posting seven consecutive days of uptrend. Glenmark and Harbour BioMed entered into an agreement to develop, manufacture and market a bispecific antibody GBR 1302 for treating HER-2 Positive Cancers for Greater China territory.

The growth in domestic revenue stood at 23 per cent, mainly driven by products launched in the recent past and good marketing strategies.